New Global Telepsychiatry Guidelines Released

The World Psychiatric Association (WPA) has released new global telemedicine guidelines. Prompted by the worldwide explosion of interest in telepsychiatry driven by the COVID-19 pandemic, the guidelines emphasize the need for international collaboration in psychiatry. “Global teamwork is the light at the end of the tunnel” of the current crisis, lead authors Davor Mucic, MD, The Little Prince Treatment Center, […]

Read more

Insomnia linked to more suicidal thoughts and disease severity in schizophrenia patients

Insomnia is a common problem in patients with schizophrenia, and a new study reinforces a close association between insomnia, more suicidal thoughts and actions and increased problems like anxiety and depression in these patients. It also provides more evidence that keeping tabs on how patients are sleeping — and intervening when needed — is important to their overall care. We […]

Read more

Study explains why antipsychotic medications lead to weight gain, promote metabolic syndrome

Why do patients who receive antipsychotic medications to manage schizophrenia and bipolar disorder quickly gain weight and develop prediabetes and hyperinsulemia? The question remained a mystery for decades, but in a paper published today in Translational Psychiatry, researchers from the University of Pittsburgh School of Medicine finally cracked the enigma. Antipsychotic drugs, scientists showed, not only block dopamine signaling in […]

Read more

Immune responses during embryo development could increase risk of schizophrenia

Past research has often highlighted the effects that immune activation in pregnant women can have on the development of human embryos, for instance increasing the risk of a child developing psychiatric disorders later in life. The neural mechanisms underpinning these effects, however, remain largely unclear. Researchers at New York Medical College have recently carried out a study investigating the impact […]

Read more

Imaging markers developed to facilitate diagnosis and treatment of schizophrenia

Around four in a thousand people worldwide suffer from schizophrenia, according to scientific estimates. The disease affects people from all walks of life, including Vincent van Gogh, the painter Agnes Martin, mathematician John Nash and Eduard Einstein, a son of the great physicist. The disease affects men and women equally. Despite its prevalence, however, schizophrenia has remained a mystery. Diagnosis […]

Read more

Determined DNA hunt reveals schizophrenia clue

An 18-year study using the DNA of thousands of people in India has identified a new clue in the quest for causes of schizophrenia, and for potential treatments. University of Queensland and Indian researchers searched the genomes of more than 3000 individuals and found those with schizophrenia were more likely to have a particular genetic variation. Professor Bryan Mowry from […]

Read more

Broccoli sprout extracts may help manage schizophrenia

Drugs used to treat schizophrenia don't work completely for everyone, and they can cause a variety of undesirable side effects, including metabolic problems increasing cardiovascular risk, involuntary movements, restlessness, stiffness and "the shakes." A chemical derived from broccoli sprouts can be used to manage schizophrenia symptoms, scientists have found, paving the way for treatments that reduces unwanted side effects of […]

Read more

Researchers find high-risk genes for schizophrenia

Using a unique computational framework they developed, a team of scientist cyber-sleuths in the Vanderbilt University Department of Molecular Physiology and Biophysics and the Vanderbilt Genetics Institute (VGI) has identified 104 high-risk genes for schizophrenia. Their discovery, which was reported April 15 in the journal Nature Neuroscience, supports the view that schizophrenia is a developmental disease, one which potentially can […]

Read more
1 2